The US Food and Drug Administration (FDA) has approved the B-cell depleting agent inebilizumab-cdon (Uplizna, Amgen) for the treatment of immunoglobulin G4-related disease (IgG4-RD). This is the first and only treatment approved for this rare autoimmune disease in the United States. An estimated 200,000 people in the United States are living with IgG4-RD...
The Center For Mind & Esteem DeveloPment, Inc. Marvin Mack, Founder Creative Director
LoveNow360 for Self, Community and World Engagement & Empowerment
The Center For Mind & Esteem Development, Inc. A Course In Personal & Professional Development LoveNow360 for Self, Community & World Engagement & Empowerment Marvin Mack, Founder & Creative Director
410-971-6235
personaldevelopment@me.com
Copyright © 2023 lovenowoutreach. All Rights Reserved
